drugset / Trial / NCT04617015

Defining and Treating Depression-related Asthma

NCT04617015

NaSingle-groupOpen-labelDiagnostic

Summary

Depression is seen more often in people with asthma, and may lead to increased development and severity of asthma. This study will investigate whether children with depression and asthma have less allergic disease and less inflammation than children with asthma who do not have symptoms of depression. The study will also investigate whether the lungs of children with depression and asthma respond to an anticholinergic inhaler called ipratropium more than the lungs of non-depressed asthmatic children.

Timeline

Start
2016-09-09
Primary completion
2019-03-11
Completion
2019-03-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ipratropium Small molecule Inhaled